Diagnosis and management of maturity onset diabetes of the young (MODY).

Diagnosis and management of maturity onset diabetes of the young (MODY).

Show other versions (2)

Bibliographic Details
Main Authors:	Thanabalasingham, G, Owen, K
Format:	Journal article
Published:	2011

Similar Items

Diagnosis and management of maturity onset diabetes of the young (MODY).
by: Thanabalasingham, G, et al.
Published: (2011)

Diagnosis and management of maturity onset diabetes of the young (MODY)
by: Thanabalasingham, G, et al.
Published: (2011)

Metabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkers.
by: Gloyn, A, et al.
Published: (2012)

Maturity onset diabetes of the young: clinical characteristics, diagnosis and management.
by: Kavvoura, F, et al.
Published: (2012)

Extending criteria for genetic testing increases diagnosis of maturity-onset diabetes of the young
by: Thanabalasingham, G, et al.
Published: (2010)

Maturity onset diabetes of the young and fibrin-related thrombosis risk
by: Sagar, RC, et al.
Published: (2020)

Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.
by: Thanabalasingham, G, et al.
Published: (2012)

Differences in thrombotic and inflammatory markers comparing subjects with maturity onset diabetes of the young and type 2 diabetes
by: Bottomley, M, et al.
Published: (2010)

Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY)
by: Li, Xiuzhen, et al.
Published: (2018)

Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetes.
by: Winckler, W, et al.
Published: (2007)

High-Throughput HPLC-based N-Glycan Analysis of Human Plasma Proteins Identifies Potential Biomarkers for Maturity Onset Diabetes of the Young (MODY)
by: Adamczyk, B, et al.
Published: (2011)

Simultaneous pancreas and kidney transplantation (SPK) should be indicated for patients with maturity-onset diabetes of the young (MODY) and end-stage nephropathy
by: Eininger, A, et al.
Published: (2013)

Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY).
by: Thomson, K, et al.
Published: (2003)

Maturity onset diabetes of the young is characterised by less thrombotic fibrin network structure compared with phenotypically similar type 2 diabetes subjects
by: Ajjan, R, et al.
Published: (2011)

Identification and assessment of glycan profiles as a biomarker for maturity onset diabetes of the young (MODY) due to hepatocyte nuclear factor 1 alpha (HNF1A) mutations
by: Gloyn, A, et al.
Published: (2011)

Molecular diagnosis of maturity-onset diabetes of the young in a cohort of Chinese children
by: Xu, Aijing, et al.
Published: (2020)

MATURITY-ONSET DIABETES IN YOUNG BLACK-AMERICANS
by: Orahilly, S, et al.
Published: (1987)

Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.
by: Owen, K, et al.
Published: (2010)

Maturity onset diabetes of the young due to HNF1A variants in Croatia
by: Pavić, T, et al.
Published: (2018)

Assessment and translation of novel biomarkers for diagnosis of maturity onset diabetes of the young due to HNF1A variants
by: Juszczak, A
Published: (2018)

Plasma fucosylated glycans and C-reactive protein as biomarkers of HNF1A-MODY in young adult–onset nonautoimmune diabetes
by: Juszczak, A, et al.
Published: (2018)

Common variants in maturity-onset diabetes of the young genes and future risk of type 2 diabetes.
by: Holmkvist, J, et al.
Published: (2008)

Lipoprotein composition in HNF1A-MODY: differentiating between HNF1A-MODY and type 2 diabetes.
by: McDonald, T, et al.
Published: (2012)

Type 2 diabetes in the young: Why we should worry
by: Thanabalasingham, G, et al.
Published: (2014)

Use of high sensitivity C-reactive protein and DG9-glycan index for differential diagnosis of maturity-onset diabetes of the young due to HNF1A mutations in young adults
by: Mughal, SA, et al.
Published: (2013)

CORRELATES OF DETERIORATING VIBRATION SENSITIVITY 3 YEARS FROM DIAGNOSIS OF MATURITY-ONSET DIABETES
by: Holman, R, et al.
Published: (1981)

MATURITY-ONSET DIABETES OF THE YOUNG IS A BETA-CELL DISORDER WITH NORMAL PROINSULIN LEVELS
by: Hattersley, A, et al.
Published: (1993)

Identification of novel and recurrent glucokinase mutations in Belgian and Luxembourg maturity onset diabetes of the young patients.
by: Vits, L, et al.
Published: (2006)

BETA CELL DEFICIENCY IN MATURITY ONSET DIABETES
by: Turner, R, et al.
Published: (1976)

Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
by: Gloyn, A
Published: (2003)

Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.
by: Osbak, K, et al.
Published: (2009)

Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia.
by: Valentinova, L, et al.
Published: (2012)

A genome scan reveals heterogeneity among European families with maturity onset diabetes of the young
by: Frayling, T, et al.
Published: (2001)

UK prospective study of therapies of maturity-onset diabetes.
by: Turner, R, et al.
Published: (1984)

Traditional clinical criteria outperform high-sensitivity C-reactive protein for the screening of hepatic nuclear factor 1 alpha maturity-onset diabetes of the young among young Asians with diabetes
by: Rama Chandran, S, et al.
Published: (2018)

High frequency of mutations in MODY and mitochondrial genes in Scandinavian patients with familial early-onset diabetes.
by: Lehto, M, et al.
Published: (1999)

A genome-wide scan in families with maturity-onset diabetes of the young: evidence for further genetic heterogeneity.
by: Frayling, T, et al.
Published: (2003)

FASTING BLOOD-GLUCOSE CONCENTRATIONS AND TREATMENT OF MATURITY-ONSET DIABETES
by: Howedavies, S, et al.
Published: (1980)

Cost–effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries
by: Szilberhorn, L, et al.
Published: (2023)

Evaluation of high sensitivity C-reactive protein as a screening tool for detecting young South Asians with maturity-onset diabetes of the young due to HNF1A mutations
by: Mughal, SA, et al.
Published: (2013)